Clinical Trial Update: A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan

View source ↗

Summary

This registry study in Japan observes clinical outcomes of participants with high-risk metastatic hormone-naïve prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Prostatic Neoplasms | Status: COMPLETED